Medicine Description coaguloban 30mg
coaguloban 30mg tablets is a medication that acts as a direct Factor Xa inhibitor. By selectively inhibiting Factor Xa, Edoxaban effectively disrupts the coagulation cascade, which is crucial in the formation of thrombin. This inhibition leads to a decrease in the conversion of prothrombin to thrombin, ultimately reducing the formation of fibrin clots. Consequently, coaguloban 30mg tablets helps prevent thromboembolic events by maintaining a balanced hemostatic environment, reducing the risk of blood clots in patients at risk.
Indications and Uses of coaguloban 30mg tablets
- Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prevention of recurrent DVT and PE following initial treatment.
Side Effects of coaguloban 30mg tablets
- Bleeding complications, such as gastrointestinal bleeding.
- Elevated liver enzymes.
- Rash or allergic reactions.
- Edema or swelling in various body parts.
- Nausea and abdominal discomfort.
Storage and Handling
Store coaguloban 30mg tablets at room temperature, away from moisture and heat. Keep the medication out of reach of children and do not use it beyond the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should be informed to report any signs of unusual bleeding or bruising. It is essential to avoid concurrent use of other anticoagulants or antiplatelet medications without consulting a healthcare provider. Routine monitoring of renal function may be advised, as renal impairment can affect drug clearance. Patients should be cautioned against sudden discontinuation of the medication without medical advice, as this may increase the risk of thrombotic events.